Congenica, UniteGen Ink Deal for Genome Analysis Platform
Jun 22, 2017 | staff reporter
NEW YORK (GenomeWeb) – Bioinformatics firm Congenica said on Wednesday that it has signed an agreement under which its Sapientia clinical genome analysis software platform will be used by Beijing-based UniteGen as part of a large-scale genomics project in China.
Sapientia is a modular and scalable data analytics tool for annotating and clinically interpreting genomic sequence data. Under the terms of the deal, UniteGen will use the platform to carry out whole-genome sequencing processing and analysis for the 100K Wellness Pioneer Project — a recently launched initiative to analyze the genomes, metabolomes, proteomes, and clinical symptoms of 100,000 Chinese individuals in order to build a database for disease prevention and health management.
Additional terms were not disclosed.
"Sapientia incorporates all the features needed by Chinese healthcare practitioners to integrate genetic testing into clinical decisions," UniteGen Founder and CEO Weike Mo said in a statement. "The automated reporting software solves a critical bottleneck for the genetic testing industry in China."
In mid-2015, Congenica was selected by Genomics England as one of four informatic companies to provide genomic interpretation services for the UK's 100,000 Genomes Project.
Congenica